Response to: Deng L, Ma A, Wood N, Ardern-Holmes S. Vaccination management in an asymptomatic child with a novel SCN1A variant and family history of status epilepticus following vaccination: A case report on a potential new direction in personalised medicine.  Seizure. 2020;78:49-52

I read this brief case report by Deng et al. with great interest. I believe that it is very important, and has significant implications on the future treatment of infants with genetic epilepsies and genetic epileptic encephalopathies. An important aspect of the case is the fact that the treatment started on this presymptomatic female infant not only prevented the disastrous consequence of immunization suffered by her brother, but also prevented the appearance of seizures which, if I understand the case report well, caused her mother, who carries us the same mutation, to have recurrent seizures since infancy not fully controlled by valproic acid.
Source: Seizure: European Journal of Epilepsy - Category: Neurology Authors: Tags: Letter to the editor Source Type: research